05 Nov PfizerPledge™: A Pilot Warranty Program for XALKORI
Over the last few months, Pfizer has quietly developed PfizerPledge™, a pilot warranty program for XALKORI that offers warranty payments to patients and health plans in full, if patients discontinue treatment for a clinical reason before the dispense of the fourth 30-day supply. Though not the first value-based initiative in the industry, PfizerPledge™ is unique in its attempt to minimize Medicaid Best Price impact and allow participation of Medicare Part D beneficiaries.
In this release, Jupiter explores the unique structure of PfizerPledge™, the rationale of launching this pilot program, and implications for the future of value-based agreements. Reach out to us at firstname.lastname@example.org to learn more.